Parkman Healthcare Partners’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.69M | Buy |
|
|||||
|
2025
Q2 | $9.03M | Buy |
|
|||||
|
2025
Q1 | $7.5M | Buy |
|
|||||
|
2024
Q4 | $1.63M | Sell |
|
|||||
|
2024
Q3 | $3.53M | Buy |
|
|||||
|
2024
Q2 | $2.47M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $7.76M | Buy |
|
|||||
|
2021
Q4 | $5.54M | Buy |
|
|||||
|
2021
Q3 | $1.47M | Sell |
|
|||||
|
2021
Q2 | $5.57M | Buy |
|
|||||
|
2021
Q1 | $2.49M | Sell |
|
|||||
|
2020
Q4 | $4.01M | Sell |
|
|||||
|
2020
Q3 | $2.75M | Sell |
|
|||||
|
2020
Q2 | $4.29M | Sell |
|
|||||
|
2020
Q1 | $1.99M | Sell |
|
|||||
|
2019
Q4 | $3.94M | Buy |
|